You have 9 free searches left this month | for more free features.

vasculitis remission

Showing 1 - 25 of 3,066

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

Recruiting
  • ANCA-associated Vasculitis
  • Maintenance Therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 20, 2023

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Trial in Boston (Rituximab)

Recruiting
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 28, 2021

Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia

Not yet recruiting
  • Granulomatosis With Polyangiitis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Dec 29, 2022

ANCA Associated Vasculitis Trial in Netherlands (Rituximab, endoxan, Methylprednisolone)

Recruiting
  • ANCA Associated Vasculitis
  • Leiden, Zuid-Holland, Netherlands
  • +3 more
May 16, 2022

Granulomatosis With Polyangiitis, Wegener Granulomatosis, Vasculitis Trial in Tampa (5 mg prednisone, 0 mg prednisone)

Active, not recruiting
  • Granulomatosis With Polyangiitis
  • +2 more
  • 5 mg prednisone
  • 0 mg prednisone
  • Tampa, Florida
    University of South Florida TAPIR Study Team
May 2, 2022

Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)

Recruiting
  • Eosinophilic Granulomatosis With Polyangiitis
  • Paris, France
    Hôpital Cochin
Feb 9, 2022

Granulomatosis With Polyangiitis Trial in Canada, United States (5 mg Prednisone, 0 mg Prednisone)

Recruiting
  • Granulomatosis With Polyangiitis
  • 5 mg Prednisone
  • 0 mg Prednisone
  • Kansas City, Kansas
  • +8 more
Jan 25, 2022

Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial in Paris (Rituximab, Placebo-rituximab, Cyclophosphamide)

Completed
  • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
  • Paris, France
    Hôpital Cochin
Apr 13, 2021

ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)

Recruiting
  • ANCA Associated Vasculitis
  • Beijing, China
    Peking Union Medical College Hospital
Jul 19, 2023

Antineutrophil Cytoplasmic Antibody-associated Vasculitis Trial (Avacopan, Placebo, Standard of Care)

Not yet recruiting
  • Antineutrophil Cytoplasmic Antibody-associated Vasculitis
  • (no location specified)
Oct 6, 2023

IgA Vasculitis Trial in France (Rituximab Injection, )

Recruiting
  • IgA Vasculitis
  • Rituximab Injection
  • placebo
  • Brest, France
  • +13 more
Apr 8, 2022

ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)

Recruiting
  • ANCA Associated Vasculitis
  • +2 more
  • Edinburgh, United Kingdom
    Centre for Cardiovascular Science, Queen's Medical Research Inst
Jan 26, 2023

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared

Recruiting
  • ANCA-associated Vasculitis
  • +2 more
    • Calgary, Alberta, Canada
    • +8 more
    Jan 27, 2023

    Subclinical Cytomegalovirus Reactivation in Acute

    Recruiting
    • ANCA Associated Vasculitis
      • Birmingham, West Midlands, United Kingdom
        University Hospitals Birmingham
      Jan 15, 2023

      Wegeners Granulomatosis (Granulomatosis With Polyangiitis), Microscopic Polyangiitis, Churg Strauss Syndrome (Eosinophilic

      Recruiting
      • Wegeners Granulomatosis (Granulomatosis With Polyangiitis)
      • +6 more
        • San Francisco, California
        • +37 more
        Nov 4, 2022

        Necrotizing Vasculitis, Neuropathy Trial in France (Necrotizing Vasculitis)

        Recruiting
        • Necrotizing Vasculitis
        • Neuropathy
        • Necrotizing Vasculitis
        • Angers, France
        • +39 more
        Jun 29, 2022

        Urinary T Lymphocytes Predict Renal Flares in Inactive

        Completed
        • Glomerulonephritis Acute
        • Analysis of urine samples with flow cytometry
        • Berlin, Germany
        • +1 more
        Mar 8, 2022

        ANCA-associated Vasculitis Trial in China (BDB-001 injection, Cyclophosphamide, Glucocorticoids)

        Recruiting
        • ANCA-associated Vasculitis
        • BDB-001 injection
        • +2 more
        • Hefei, Anhui, China
        • +19 more
        Apr 29, 2022

        Severity in Juvenile and Adult-onset Dermatomyositis

        Not yet recruiting
        • Dermatomyositis
        • evaluation of clinical severity
        • (no location specified)
        Aug 16, 2023

        POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia Trial in Hangzhou (CD19/BCMA CAR T-cells)

        Recruiting
        • POEMS Syndrome
        • +3 more
        • CD19/BCMA CAR T-cells
        • Hangzhou, Zhejiang, China
          The first affiliated hospital of medical college of zhejiang uni
        Feb 21, 2022

        Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Paris (Rituximab,

        Not yet recruiting
        • Granulomatosis With Polyangiitis
        • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
        • Paris, France
          Hôpital de la Croix Saint Simon
        Oct 10, 2022

        ANCA Associated Vasculitis, Microscopic Polyangiitis, Churg-Strauss Syndrome Trial in United Kingdom (Hydroxychloroquine,

        Recruiting
        • ANCA Associated Vasculitis
        • +3 more
        • Cardiff, United Kingdom
        • +8 more
        Mar 17, 2022

        Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis Trial in Worldwide

        Completed
        • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
        • +2 more
        • Los Angeles, California
        • +37 more
        Feb 18, 2022

        Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

        Recruiting
        • Giant Cell Arteritis
        • Bonn, Germany
          Medical Clinic and Polyclinic III Internal medicine Oncology, He
        Dec 16, 2022

        ANCA Associated Vasculitis, Granulomatosis With Polyangiitis Trial in United Kingdom (Belimumab, Rituximab, Prednisolone)

        Active, not recruiting
        • ANCA Associated Vasculitis
        • Granulomatosis With Polyangiitis
        • Cambridge, United Kingdom
        • +5 more
        Feb 21, 2022